Drosophila pain sensitization and modulation unveiled by a novel pain model and analgesic drugs

Central GABAergic neuromodulation of nocifensive behaviors in bumble bees

In mammals, nocifensive behaviors are modulated by neuroactive compounds indicating a complex pain-processing system. This study aimed to assess the role of gamma-aminobutyric acid (GABA) in modulating nocifensive behaviors in the bumble bee Bombus terrestris to better understand how pain-like behaviors are regulated in insects. Results showed that oral administration of gabapentin (0.24 mg/mL), a GABAergic analgesic acting at the central level, reduced heat sensitivity, making bees more likely to pass through a tunnel heated to 50°C, and suppressed their nocifensive behaviors. Gene expression analysis revealed a significant increase in brain expression of GAD1 in response to noxious stimulation. These findings indicate that GABA plays a key role in modulating nocifensive behaviors in insects, similar to its role in mammals, suggesting that insects may possess mechanisms for pain modulation that go beyond simple peripheral responses.

Neurophysiology of corneal neuropathic pain and emerging pharmacotherapeutics

The altered activity generated by corneal neuronal injury can result in morphological and physiological changes in the architecture of synaptic connections in the nervous system. These changes can alter the sensitivity of neurons (both second-order and higher-order projection) projecting pain signals. A complex process involving different cell types, molecules, nerves, dendritic cells, neurokines, neuropeptides, and axon guidance molecules causes a high level of sensory rearrangement, which is germane to all the phases in the pathomechanism of corneal neuropathic pain. Immune cells migrating to the region of nerve injury assist in pain generation by secreting neurokines that ensure nerve depolarization. Furthermore, excitability in the central pain pathway is perpetuated by local activation of microglia in the trigeminal ganglion and alterations of the descending inhibitory modulation for corneal pain arriving from central nervous system. Corneal neuropathic pain may be facilitated by dysfunctional structures in the central somatosensory nervous system due to a lesion, altered synaptogenesis, or genetic abnormality. Understanding these important pathways will provide novel therapeutic insight.